Literature DB >> 22420867

Weak D caused by a founder deletion in the RHD gene.

Yann Fichou1, Jian-Min Chen, Cédric Le Maréchal, Déborah Jamet, Isabelle Dupont, Claude Chuteau, Cécile Durousseau, Marie-Jeanne Loirat, Pascal Bailly, Claude Férec.   

Abstract

BACKGROUND: The RhD blood group system exemplifies a genotype-phenotype correlation by virtue of its highly polymorphic and immunogenic nature. Weak D phenotypes are generally thought to result from missense mutations leading to quantitative change of the D antigen in the red blood cell membrane or intracellularly. STUDY DESIGN AND METHODS: Different sets of polymerase chain reaction primers were designed to map and clone a deletion involving RHD Exon 10, which was found in approximately 3% of approximately 2000 RHD hemizygous subjects with D phenotype ambiguity. D antigen density was measured by flow cytometry. Transcript analysis was carried out by 3'-rapid amplification of complementary DNA ends. Haplotype analysis was performed by microsatellite genotyping.
RESULTS: A 5405-bp deletion that removed nearly two-thirds of Intron 9 and almost all of Exon 10 of the RHD gene was characterized. It is predicted to result in the replacement of the last eight amino acids of the wild-type RhD protein by another four amino acids. The mean RhD antigen density from two deletion carriers was determined to be only 30. A consensus haplotype could be deduced from the deletion carriers based on the microsatellite genotyping data.
CONCLUSION: The currently reported deletion was derived from a common founder. This deletion appears to represent not only the first large deletion associated with weak D but also the weakest of weak D alleles so far reported. This highly unusual genotype-phenotype relationship may be attributable to the additive effect of three distinct mechanisms that affect mRNA formation, mRNA stability, and RhD/ankyrin-R interaction, respectively.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22420867     DOI: 10.1111/j.1537-2995.2012.03606.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  RHD PCR of D-Negative Blood Donors.

Authors:  Franz F Wagner
Journal:  Transfus Med Hemother       Date:  2013-05-08       Impact factor: 3.747

2.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

3.  RHD variants in Polish blood donors routinely typed as D-.

Authors:  Agnieszka Orzińska; Katarzyna Guz; Helene Polin; Monika Pelc-Kłopotowska; Justyna Bednarz; Agata Gieleżyńska; Beata Sliwa; Małgorzata Kowalewska; Elżbieta Pawłowska; Bogusława Włodarczyk; Małgorzata Malaga Alicja Żmudzin; Magdalena Krzemienowska; Kshitij Srivastava; Bogumiła Michalewska; Christian Gabriel; Willy A Flegel; Ewa Brojer
Journal:  Transfusion       Date:  2013-05-01       Impact factor: 3.157

Review 4.  Frameshift variations in the RHD coding sequence: Molecular mechanisms permitting protein expression.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2020-10-09       Impact factor: 3.337

5.  Effects of RHD gene polymorphisms on distinguishing weak D or DEL from RhD- in blood donation in a Chinese population.

Authors:  Jie Shi; Ying Luo
Journal:  Mol Genet Genomic Med       Date:  2019-04-05       Impact factor: 2.183

6.  Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes.

Authors:  Kshitij Srivastava; David Alan Stiles; Franz Friedrich Wagner; Willy Albert Flegel
Journal:  J Hum Genet       Date:  2017-11-16       Impact factor: 3.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.